OGAST 30 mg, gastro-resistant capsule, box of 28

 

Active ingredient

Lansoprazole

 

OGAST is usually prescribed for:

Duodenal ulcer

Gastric ulcer

Gastroesophageal reflux esophagitis

Prevention of reflux esophagitis

Eradication of Helicobacter pylori in case of peptic ulcer disease

NSAID-Induced Duodenal Ulcer and Gastric Ulcer in Patients Requiring Continuing Treatment

Prevention of NSAID-induced duodenal ulcer and gastric ulcer in patients at risk

Gastroesophageal reflux

Zollinger-Ellison syndrome

Indications OGAST-

Treatment of duodenal ulcer and gastric ulcer

Treatment of reflux esophagitis

Prevention of reflux esophagitis

Eradication of Helicobacter pylori (H. pylori) by concomitant administration of appropriate antibiotic therapy for the treatment of ulcers associated with H. pylori

Treatment of duodenal ulcer and benign gastric ulcer, induced by NSAIDs in patients requiring continuous treatment with NSAIDs

Prevention of NSAID-induced duodenal ulcer and gastric ulcer in patients at risk (see section Dosage and method of administration) requiring continuous treatment with NSAIDs

symptomatic gastroesophageal reflux disease

Zollinger-Ellison syndrome.

OGAST is indicated in adults.